Masayo Yamazaki

2.7k total citations · 1 hit paper
33 papers, 2.0k citations indexed

About

Masayo Yamazaki is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Masayo Yamazaki has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Masayo Yamazaki's work include Drug Transport and Resistance Mechanisms (19 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Masayo Yamazaki is often cited by papers focused on Drug Transport and Resistance Mechanisms (19 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Masayo Yamazaki collaborates with scholars based in Japan, United States and Canada. Masayo Yamazaki's co-authors include Jiunn H. Lin, Jerome Hochman, Masato Chiba, Yuichi Sugiyama, Tomoyuki Ohe, I‐Wu Chen, Joy A. Nishime, William Neway, Janice Rowe and J H Lin and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Hepatology.

In The Last Decade

Masayo Yamazaki

33 papers receiving 2.0k citations

Hit Papers

Role of P-Glycoprotein in Pharmacokinetics 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayo Yamazaki Japan 20 1.2k 723 533 435 257 33 2.0k
Praveen Balimane United States 21 952 0.8× 380 0.5× 334 0.6× 559 1.3× 260 1.0× 34 2.1k
Katherine S. Fenner United Kingdom 20 1.0k 0.9× 483 0.7× 619 1.2× 337 0.8× 158 0.6× 28 1.7k
Liang‐Shang Gan United States 25 953 0.8× 379 0.5× 759 1.4× 843 1.9× 156 0.6× 43 2.4k
Jouko Laitila Finland 25 845 0.7× 422 0.6× 1.0k 1.9× 371 0.9× 200 0.8× 33 2.1k
Yoshiyuki Shirasaka Japan 29 1.4k 1.1× 659 0.9× 569 1.1× 549 1.3× 150 0.6× 83 2.4k
Miki Katoh Japan 31 949 0.8× 469 0.6× 1.2k 2.2× 827 1.9× 95 0.4× 86 2.5k
Kenneth R. Brouwer United States 24 1.4k 1.2× 749 1.0× 647 1.2× 277 0.6× 245 1.0× 54 2.1k
A. David Rodrigues United States 31 1.3k 1.1× 647 0.9× 1.1k 2.2× 444 1.0× 377 1.5× 73 2.5k
David R. Jones United States 19 765 0.6× 311 0.4× 979 1.8× 576 1.3× 373 1.5× 35 2.3k
Kazuhide Iwasaki Japan 26 683 0.6× 415 0.6× 931 1.7× 502 1.2× 123 0.5× 68 2.0k

Countries citing papers authored by Masayo Yamazaki

Since Specialization
Citations

This map shows the geographic impact of Masayo Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayo Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayo Yamazaki more than expected).

Fields of papers citing papers by Masayo Yamazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayo Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayo Yamazaki. The network helps show where Masayo Yamazaki may publish in the future.

Co-authorship network of co-authors of Masayo Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masayo Yamazaki. A scholar is included among the top collaborators of Masayo Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayo Yamazaki. Masayo Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tajima, Toshihiro, et al.. (2019). Recent advances in research on isolated congenital central hypothyroidism. Clinical Pediatric Endocrinology. 28(3). 69–79. 3 indexed citations
2.
Ikeda, Takahiro, Hitoshi Osaka, Hiroko Shimbo, et al.. (2018). Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome. Human Genome Variation. 5(1). 25–25. 24 indexed citations
3.
5.
Sandhu, Punam, Wooin Lee, Xin Xu, et al.. (2005). HEPATIC UPTAKE OF THE NOVEL ANTIFUNGAL AGENT CASPOFUNGIN. Drug Metabolism and Disposition. 33(5). 676–682. 83 indexed citations
6.
Lin, Jiunn H. & Masayo Yamazaki. (2003). Role of P-Glycoprotein in Pharmacokinetics. Clinical Pharmacokinetics. 42(1). 59–98. 756 indexed citations breakdown →
7.
Lin, Jiunn H. & Masayo Yamazaki. (2003). Clinical Relevance of P-Glycoprotein in Drug Therapy. Drug Metabolism Reviews. 35(4). 417–454. 121 indexed citations
8.
Ohe, Tomoyuki, Masahiko Sato, Sachiko Tanaka, et al.. (2003). EFFECT OF P-GLYCOPROTEIN-MEDIATED EFFLUX ON CEREBROSPINAL FLUID/PLASMA CONCENTRATION RATIO. Drug Metabolism and Disposition. 31(10). 1251–1254. 36 indexed citations
9.
Kumar, Sanjeev, Gloria Y. Kwei, Grace K. Poon, et al.. (2003). Pharmacokinetics and Interactions of a Novel Antagonist of Chemokine Receptor 5 (CCR5) with Ritonavir in Rats and Monkeys: Role of CYP3A and P-Glycoprotein. Journal of Pharmacology and Experimental Therapeutics. 304(3). 1161–1171. 19 indexed citations
10.
Hochman, Jerome, Masayo Yamazaki, Tomoyuki Ohe, & Jiunn H. Lin. (2002). Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein. Current Drug Metabolism. 3(3). 257–273. 70 indexed citations
11.
Hochman, Jerome, Masato Chiba, Joy A. Nishime, Masayo Yamazaki, & J H Lin. (2000). Influence of P-Glycoprotein on the Transport and Metabolism of Indinavir in Caco-2 Cells Expressing Cytochrome P-450 3A4. Journal of Pharmacology and Experimental Therapeutics. 292(1). 310–318. 103 indexed citations
12.
Lin, Jiunn H., Masato Chiba, I‐Wu Chen, et al.. (1999). Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction. Drug Metabolism and Disposition. 27(10). 1187–1193. 34 indexed citations
13.
Gao, Mian, Masayo Yamazaki, Douglas W. Loe, et al.. (1998). Multidrug Resistance Protein. Journal of Biological Chemistry. 273(17). 10733–10740. 71 indexed citations
14.
Yamazaki, Masayo, Kazuo Kobayashi, & Yuichi Sugiyama. (1996). PRIMARY ACTIVE TRANSPORT OF PRAVASTATIN ACROSS THE LIVER CANALICULAR MEMBRANE IN NORMAL AND MUTANT EISAI HYPERBILIRUBINEMIC RATS. Biopharmaceutics & Drug Disposition. 17(7). 607–621. 25 indexed citations
15.
Yamazaki, Masayo, Kazuo Kobayashi, & Yuichi Sugiyama. (1996). PRIMARY ACTIVE TRANSPORT OF PROVASTATIN ACROSS THE LIVER CANALICULAR MEMBRANE IN NORMAL AND MUTANT EISAI HYPERBILIRUBINAEMIC RATS. Biopharmaceutics & Drug Disposition. 17(8). 645–659. 48 indexed citations
16.
Yamazaki, Masayo, Yuichi Sugiyama, Hiroshi Suzuki, Tatsuji Iga, & Manabu Hanano. (1992). Utilization of ATP-depleted cells in the analysis of taurocholate uptake by isolated rat hepatocytes. Journal of Hepatology. 14(1). 54–63. 10 indexed citations
17.
Harashima, Hideyoshi, Masayo Yamazaki, Yuichi Sugiyama, et al.. (1992). Significance of binding to Na,K-ATPase in the tissue distribution of ouabain in guinea pigs.. Pharmaceutical Research. 9(4). 474–479. 6 indexed citations
18.
Okudaira, Kazuho, Masayo Yamazaki, Yasufumi Sawada, et al.. (1992). Correlation Between the Inhibitory Effects of Basic Drugs on the Uptake of Cardiac Glycosides and Taurocholate by Isolated Rat Hepatocytes. Pharmaceutical Research. 9(9). 1152–1156. 16 indexed citations
19.
Koto, Shinkiti, et al.. (1982). . NIPPON KAGAKU KAISHI. 1651–1656. 5 indexed citations
20.
Morishima, Naohiko, Shinkiti Koto, Yosuke Hashimoto, et al.. (1982). STEREOSELECTIVITY IN THE DEHYDRATIVE GLYCOSYLATION WITH HEPTA-O-BENZYL-GLUCOBIOSES. Chemistry Letters. 11(9). 1383–1384. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026